Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
11/2003
11/20/2003US20030215443 Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders
11/20/2003US20030215442 Methods and compositions for the treatment or prevention of immune disorders using combination therapy
11/20/2003US20030215436 Anitmicrobial polymer conjugates
11/20/2003US20030215426 Redifferentiated cells for repairing cartilage defects
11/20/2003US20030215408 Combination antiperspirant and antimicrobial composition
11/20/2003US20030215401 Potassium or strontium salt as a nerve desensitizing agent; tubule blocking agent, that may be a hydrolyzed long-chain olefin-maleic anhydride copolymer
11/20/2003US20030215388 Can be administered in conjunction with radiation or chemotherapeutic agents.
11/20/2003CA2492394A1 Induction of antigen specific immunologic tolerance
11/20/2003CA2492044A1 Ldl receptor-related proteins 1 and 2 and treatment of bone or cartilage conditions
11/20/2003CA2490989A1 Methods and compositions for the treatment of graft failure
11/20/2003CA2486075A1 Abuse-resistant opioid solid dosage form
11/20/2003CA2485373A1 Epha2 monoclonal antibodies and methods of use thereof
11/20/2003CA2484897A1 Soluble st2 as a cardiovascular disease marker and therapeutic target
11/20/2003CA2484829A1 Methods and compositions for treating tinea versicolor using combinations of retinoids and certain antifungals
11/20/2003CA2484736A1 Gallocatechin gallate-containing composition
11/20/2003CA2484637A1 Nanoparticulate nystatin formulations
11/20/2003CA2484276A1 Combination of a proton pump inhibitor and a respiratory agent for the treatment of respiratory diseases
11/20/2003CA2484272A1 New combination of reversible proton pump inhibitors and airway therapeutics for treating airway disorders
11/20/2003CA2484144A1 Eif-5a nucleic acids for inhibiting apoptosis
11/20/2003CA2482541A1 Use of valsartan or its metabolite to inhibit platelet aggregation
11/20/2003CA2462203A1 Methods and products for enhancing immune responses using imidazoquinoline compounds
11/19/2003EP1362916A2 Human tumor necrosis factor delta and epsilon
11/19/2003EP1362598A1 Active oxygen generator containing photosensitizer for ultrasonic therapy
11/19/2003EP1362596A2 Inhibitor of stem cell proliferation and uses thereof
11/19/2003EP1362591A1 Use of a composition containing 5-androstene-3 beta, 17-alpha diol
11/19/2003EP1362590A1 Use of cilobradine or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
11/19/2003EP1362588A1 Medicinal compositions comprising diclofenac and ornoprostil
11/19/2003EP1362585A2 Pharmaceutical compositions containing a cox-ii inhibitor and a muscle relaxant
11/19/2003EP1362581A2 Combination antiperspirant and antimicrobial compositions
11/19/2003EP1362108A2 Novel human protease and polynucleotides encoding the same
11/19/2003EP1362039A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands
11/19/2003EP1362031A1 Pharmaceutically active piperidine derivatives
11/19/2003EP1361899A2 Devices and methods for the treatment of cancer
11/19/2003EP1361897A2 Methods for inhibiting pain
11/19/2003EP1361893A1 Modified anti-egfr antibodies with reduced immunogenicity
11/19/2003EP1361888A2 Method of treating neurologcial diseases
11/19/2003EP1361884A2 Sensitization of chemotherapeutic agent resistant neoplastic cells with reovirus
11/19/2003EP1361878A1 Treatment of parkinson's disease by the combined action of a compound with neurotrophic activity and a compound enhancing the dopamine activity
11/19/2003EP1361875A2 Novel heterocyclic amide derivatives and their use as dopamine d3 receptor ligands
11/19/2003EP1361874A1 Treatment of diseases characterized by excessive or insufficient cell death
11/19/2003EP1361870A2 A substance for use in a dietary supplement or for the preparation of a medicament for the treatment of non-insulin dependent diabetes mellitus, hypertension and/or the metabolic syndrome
11/19/2003EP1361868A1 Novel modified release formulation
11/19/2003EP1361867A1 Fibrate-statin combinations with reduced fed-fasted effects
11/19/2003EP1361865A2 Cubic liquid crystalline compositions and methods for their preparation
11/19/2003EP1196153B1 Process for the improvement of spermatozoa fertilization activity
11/19/2003EP1117401B1 Antibiotic compositions for treatment of the eye
11/19/2003EP0973392B1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds
11/19/2003EP0967997B1 Pharmaceutical composition for eliminating membrane-mediated cell resistance
11/19/2003EP0914111B1 Prevention and treatment of cachexia and anorexia
11/19/2003EP0851753B1 Aerosol compositions
11/19/2003EP0783292B1 Inhibition of hair growth
11/19/2003EP0756477B1 Methods for phototherapeutic treatment of proliferative skin diseases
11/19/2003EP0733066B1 Pretargeting methods and compounds
11/19/2003CN1457261A Method and compositions for prevention or treatment of cancer
11/19/2003CN1456356A Gene carrier for therapy of cerebral gliocyte diseases
11/19/2003CN1456353A Senile dementia vaccinum and preparing method thereof
11/19/2003CN1127984C Pharmaceutical composition having enhanced antitumor activity and/or reduced side effects, containing antitumor agent and hydroxamic acid derivative
11/18/2003US6649737 Human galactosyltranferases
11/18/2003US6649657 Prevention of loss and restoration of bone mass by certain prostaglandin agonists
11/18/2003US6649645 Combination therapy of radiation and a COX-2 inhibitor for treatment of neoplasia
11/18/2003US6649644 Method of treating HIV infection by combined use of a cytotoxic agent and a non-nucleoside reverse transcriptase inhibitor
11/18/2003US6649641 Glucagon antagonists/inverse agonists
11/18/2003US6649640 Isoxazole compositions useful as inhibitors of ERK
11/18/2003US6649629 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
11/18/2003US6649625 Agent for prophylaxis and treatment of glaucoma
11/18/2003US6649622 Treating diabetes, especially Type II diabetes
11/18/2003US6649614 Psychological disorders
11/18/2003US6649607 Compositions and methods for treating or preventing convulsions or seizures
11/18/2003US6649602 Vernal keratoconjunctivitis, giant papillary conjunctivitis, atopic keratoconjunctivitis
11/18/2003US6649589 Blocking tumor necrosis factor activity with soluble cytokine receptor, monoclonal antibody or tetracycline derivative
11/18/2003US6649391 Isolated polynucleotide encoding a polypeptide of given sequence; dephosphorylates MAP(mitogen activated protein)-kinase; used for modulating cell proliferation, differentiation and survival
11/18/2003US6649389 Peptide for use in the diagnosis and treatment of cancer, thyroid, diabetes, atherosclerosis, and cardiovascular disorders
11/18/2003US6649388 Polypeptides derived from JNK3
11/18/2003US6649366 Methods and compositions related to modulators of annexin and cartilage homeostasis
11/18/2003US6649157 Treating a Ras-mediated cell proliferative disorder in a mammal, by administering a modified adenovirus, modified HSV, modified vaccinia virus or modified parapoxvirus orf virus resulting in lysis of the proliferating cells.
11/18/2003CA2285490C Composition for improvement of cellular nutrition and mitochondrial energetics
11/16/2003CA2386648A1 Compositions and methods for managing bacterial skin conditions
11/13/2003WO2003093499A2 Therapeutic use of selective pde10 inhibitors
11/13/2003WO2003093478A1 Immunoconjugates for the treatment of tumours
11/13/2003WO2003093443A2 Alcam and alcam modulators
11/13/2003WO2003093409A2 Promoters exhibiting endothelial cell specificity and methods of using same
11/13/2003WO2003093322A2 Carrageenan based antimicrobial compositions
11/13/2003WO2003093267A1 7-aryl-3,9-diazabicyclo(3.3.1)non-6-ene derivatives and their use as renin inhibitors in the treatment of hypertension, cardiovascular or renal diseases
11/13/2003WO2003092815A1 Method and agents for the prevention, inhibition, and therapy of cancers
11/13/2003WO2003092790A2 Methods for increasing the therapeutic response to electroconvulsive therapy ('ect')
11/13/2003WO2003092763A1 Carbon nanotubules for storage of nitric oxide
11/13/2003WO2003092761A1 Surgical material comprising water glass fibres
11/13/2003WO2003092737A1 Fusions of cytokines and tumor targeting proteins
11/13/2003WO2003092732A1 Ph-sensitive polymer
11/13/2003WO2003092729A1 Stable pharmaceutical formulation for a combination of a statin and an ace inhibitor
11/13/2003WO2003092721A1 A combination product comprising melagatran and an anti-arrhythmic oxabispidenes
11/13/2003WO2003092720A1 A combination product comprising an anti-coagulant and anti-arrhythmic oxabispidenes
11/13/2003WO2003092716A2 Therapeutic use of pacap, maxadilan, pacap receptor agonist and/or adcyap1r1 in the treatment of cns disorders
11/13/2003WO2003092706A1 Re-epithelializing pharmaceutical compositions comprising xanthan gum
11/13/2003WO2003092703A1 Methods and compositions for inhibition or irritation by disaccharide and metal ions
11/13/2003WO2003092697A1 Therapeutic 1,2,3,6-tetrahydropyrimidine-2-one compositions and methods therewith
11/13/2003WO2003092694A1 Treatment of diabetes and diabetic complications with nhe-1 inhibitors
11/13/2003WO2003092693A1 Methods of treatment of glaucoma and other conditions mediated by nos-2 expression via inhibition of the egfr pathway
11/13/2003WO2003092691A1 Combination of cyclooxygenase-2 inhibitors and thalidomide for the treatment of neoplasia
11/13/2003WO2003092687A1 Methods of modulating smooth muscle contractility
1 ... 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 660 661 662 663 664 ... 1151